RxDoctor Payments Data

Justin Okray

Medical · Chicago, ILNPI 1639572902

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $4,378 of the $5,242 with a category attached, or 83.5%. Abbott accounts for 61.7% of it on its own, with 14 other manufacturers making up the rest. Reporting peaked in 2023 at $2,657 and has fallen 81.0% since, to $505 in 2025.

$5,242in general payments, 2019–2025

Across 123 payments — averaging $42.62 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Abbott$3K
  • Abiomed$1K
  • Medtronic$337
  • Amgen$140
  • Cvrx, Inc.$135
  • AstraZeneca$124
  • plus $262 from 9 others

What the payments were for

  • Travel & lodging$83416%
  • Food & beverage$4,37884%
  • Entertainment$301%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$5,242 in reported general payments places this provider in the 85th percentile of 449 medical providers in Illinois.

See all medical providers in Illinois

Medicare billing

Part B allowed, 2024
$10,996
Medicare patients
43
Services billed
186

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
JardianceEmpagliflozin13$7,813
Ceftazidime38$7,484
Mexiletine Hcl25$2,005
Sildenafil Citrate11$1,184
Warfarin Sodium123$917
Doxycycline Hyclate19$802
Cephalexin17$737
Potassium Chloride20$543
Bumetanide14$533
Digoxin25$418
Atorvastatin Calcium30$292
Pantoprazole Sodium27$276
Gabapentin11$258
Spironolactone22$233
Losartan Potassium26$208

Paid to pharmacies, not to this prescriber.

Other medical in Chicago

See the full list for Illinois

Where these figures come from

Is this you, or does something look wrong? →